alt import antigen actinobacillu pleuropneumonia app shown provide partial protect infect previous studi lab main purpose present investing induce crossprotect differ serotyp lucid key meghan immune response antigen stimuli bioinformat analysis demons highly conserve gene wide distribute across multiple pathogen strain homolog two rang regard loc indirect enzymelink immunosorb assay lisa confirm specify antibody could inactive l m whole cell bacteria prepare recombin fusion protein derive howe proven effect crossprotect several b histopatholog examine vaccine anim show le sever pathology sign lung tissue neg control challenge immunohistochem hc india infiltr neutrophil group significantly increase compare normal control p survive decrease antigalt media phagocytosi interact survive rate challenge reduce use potent vaccine candid 